Nierhaus, Axel
,
Bloos, Frank
Wilson, Darius Cameron
Elke, Gunnar
Meybohm, Patrick
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01 KI 0106)
Biosyn GmbH
Thermo Fisher Scientific
Article History
Received: 9 July 2018
Accepted: 25 July 2018
First Online: 20 August 2018
Ethics approval and consent to participate
: The study protocol of the SISPCT trial was approved by the ethics board of Jena University Hospital (internal file number 2242–03/08). Written informed consent was obtained from all patients or their legal representatives.
: No individual participant data are reported that would require consent to publish from the participant (or legal parent or guardian for children).
: All authors have provided information on potential conflicts of interests directly or indirectly related to the work submitted in the journal’s disclosure forms. AN reported receiving lecture honoraria from Thermo Fisher Scientific. FB reported receiving lecture honoraria from biosyn, Gilead and CSL Behring and public funding for the SISPCT trial to his department by the German Federal Ministry of Education and Research, as well as unrestricted research grants for the SISPCT trial by biosyn and Thermo Fisher Scientific. DCW is an employee of BRAHMS GmbH. The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.